Thank you to our ACRO 2025 sponsors!

Want to join this list of sponsors for ACRO 2025: The Radiation Oncology Summit?

Email our Industry Relations Manager Lencie Gradishar today!

Corporate Sponsors

Diamond Members:

At Varian, a Siemens Healthineers company, we envision a world without fear of cancer. For more than 75 years, Varian has developed, built, and delivered innovative technologies and solutions that help care providers around the globe treat millions of patients each year. Today, as a Siemens Healthineers company, we support every step of the cancer care journey – from screening to survivorship. From advanced imaging and radiation therapy to comprehensive software and services, to interventional radiology, we are harnessing the power of our perspective while also pursuing clinical research to create a more efficient, and more personalized care pathway. Because, for cancer patients everywhere, their fight is our fight. For more information, visit http://www.varian.com.   

Gold Members:

AstraZeneca  is a global, science-led biopharmaceutical company that focuses on the discovery, development, and commercialization of prescription medicines in Oncology, Rare Diseases, and BioPharmaceuticals, including Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. Based in Cambridge, UK, AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide.

GammaTile is an FDA-cleared, bioabsorbable collagen implant embedded with radiation seeds, designed for patients with operable brain tumors. By delivering radiation directly from within—placed into the surgical cavity at the time of tumor removal—GammaTile  provides immediate, localized treatment.

Myriad Genetics is a leading genetic testing and precision medicine company based in Salt Lake City, Utah. Providing insights that help people take control of their health and enable healthcare providers to better detect, treat, and prevent disease. Learn more about Myriad’s urology tests here.

Novocure is a global oncology company working to extend survival in some of the most aggressive forms of cancer through the development and commercialization of its innovative therapy, Tumor Treating Fields. To learn more, visit Novocure.com

Silver Members:

Bayer  is committed to delivering science for a better life by advancing a portfolio of innovative oncology treatments. We prioritize patients’ needs by researching and developing medicines that have the potential to enhance cancer treatment. With passion, dedication, and determination, we explore new targets and pathways in multiple forms of cancers. Our oncology franchise includes products and compounds in various stages of clinical development, aiming to make a meaningful impact on patient care.

Barrigel, by Teleflex, is an injectable biodegradable rectal spacer that separates the prostate from the rectum to protect it during radiation therapy treatment for prostate cancer. A groundbreaking spacing technology, it is the first and only hyaluronic acid, visually-guided, sculptable spacer for customizable coverage. Learn more at  Barrigel Spacer | Minimize Prostate Radiation Side Effects 

Bronze Members:

Beekley Medical's broad range of single-use disposable products for radiation oncology help you save time, improve clinical efficacy, maximize productivity, and create a more positive patient experience in all areas of treatment planning. 

Blue Earth Diagnostics, one of the Bracco family of companies, is a recognized global industry leader in the development and commercialization of innovative, precision imaging radiopharmaceuticals that help to diagnose, stage and monitor cancer for patients in areas of unmet medical need. Formed in 2014, Blue Earth Diagnostics is led by proven experts in nuclear medicine, with a demonstrated track record in the rapid development and commercialization of positron emission tomography (PET) radiopharmaceuticals with a consistent commitment to providing service to its customers. Blue Earth Diagnostics’ products include a world-class franchise of PET diagnostic imaging agents for prostate cancer and an expanding pipeline portfolio that spans a variety of disease states, including neuro-oncology and multiple solid tumors.  For more information, visit: www.blueearthdiagnostics.com

RefleXion is an external-beam theranostic oncology company pioneering SCINTIX® biology-guided radiotherapy – a breakthrough treatment that detects and responds to signals emitted from the cancer itself and, for the first time, uses them to autonomously direct precise radiation. The RefleXion® X1 with SCINTIX therapy treats multiple tumors in a single treatment plan and enables radiotherapy for all stages of cancer.

Vision RT:  For more than 20 years, Vision RT has been on a mission to make radiation therapy more effective for cancer patients. 
We are the inventors of, and market leaders in, Surface Guided Radiation Therapy (SGRT) which uses 3D cameras to help guide radiation therapy at every step: Sim, Planning and Treatment.

Exhibitors:

Accuray

Artera is a leading precision medicine company developing AI tests to personalize cancer therapy. Artera offers an AI-enabled test that is the first of its kind to provide both prognostic and predictive results for patients with localized prostate cancer: ArteraAI Prostate Test.

Best Medical International specializes in high-quality, innovative solutions for external beam radiation therapy, brachytherapy, and vascular brachytherapy and along w/other TeamBest companies, manufactures cyclotrons, GammaBeam teletherapy systems, blood irradiators, particle therapy accelerators, ultrasound imaging systems, Iodine-125/Palladium-103 seeds, needles, templates, applicators, fiducial markers, dosimeter systems, NovosteTM Beta-CathTM System and more.

BioProtect Medical, Inc  is a technology platform company that provides innovative biodegradable spacing solutions. Currently commercially available is our BioProtect Balloon, which addresses radiation-induced rectal toxicity in prostate cancer patients.

At Brainlab, we digitize medical workflows, from diagnosis to therapy, to offer clinicians and patients better treatment possibilities. Our innovative digital ecosystem forms the basis for modern healthcare technology in 6700 hospitals in 127 countries. At the forefront of health technology for over 35 years, Munich-based Brainlab employs around 2400 people with expertise across the entire healthcare value chain in 25 locations worldwide.
Like and follow Brainlab on LinkedIn, Twitter, Facebook and Instagram.

   

Headquartered in Calgary, Alberta, Canada, CDR Systems designs and manufactures innovative patient positioning and immobilization products. We are dedicated to providing superior outcomes for both patients and healthcare providers around the world. Our products play a vital role in the accuracy of a cancer patients Radiotherapy treatment.

C-RAD is a global leader in advanced radiation therapy solutions, specializing in surface guided radiation therapy (SGRT) technology. Their innovative systems enhance patient safety, improve treatment accuracy, and streamline workflows for cancer care. C-RAD's offerings are compatible with major linac and proton therapy treatment systems and provide seamless integration and future-proof solutions. 

Decipher by Veracyte:  Veracyte offers the Decipher Prostate Genomic Classifier to help with treatment planning for prostate cancer. Decipher Prostate provides prognostic information to help assess each patient’s individual risk and has been validated in over 85 studies as the most accurate predictor of metastasis, prostate cancer-specific mortality, and overall survival.

DYN’R US Inc.   is the US distributor of the SDX Respiratory Gating System. Used in 18 proton centers and over 45 radiotherapy centers, SDX system provides real-time lung volume measurement. Integration for automatic beam delivery is available for Varian, IBA, and Mevion, Leo Cancer Care treatment machines.

   

Empower HCPis a full-service healthcare compliance and networking firm specializing in comprehensive compliance solutions for healthcare providers and systems. Compliance is the glue that holds the healthcare industry together and ensures that patients receive high-quality care in a safe and ethical environment. Our mission is to empower our clients with the tools, resources, and knowledge they need to navigate the complex regulatory landscape.

Fuse Oncology provides a modern software suite for radiation oncology that leverages AI to improve clinical efficiency allowing clinicians to focus more on patient care.

At GE HealthCare, we believe that physicists and their care team colleagues should be equipped with the best technology as they help patients fight cancer. As such, across Radiology, Radiation Therapy, and Nuclear Medicine, we continue to innovate internally, collaborate externally, and acquire user-friendly and cutting-edge technology – all in the name of great Oncology care.

Gold Anchor is a great fiducial marker: our industry leading thin needles enable safe implantation in almost any inner organ; the unique folding marker design allows shortened lead time between implantation and CT/MRI; and the patented marker material (0.5% pure iron in an alloy with gold) provides enhanced MRI visibility.

IBA Dosimetry offers advanced dosimetry solutions specifically designed for medical physicists.  IBA’s innovative products and services focus on precise radiation dose measurement and quality assurance, empowering physicists to optimize treatment plans, ensure accurate dose delivery, and maintain compliance with regulatory standards, all essential for safe and effective cancer therapy.

Intelihub uses a proprietary platform to streamline revenue cycle management—making it faster, more affordable, and more effective than ever. Our system reduces errors, denials, and audits while maximizing reimbursement. Clients see claim-to-close timelines cut by 50% or more, saving time and money. Faster. Smarter. Better. Intelihub.

Jubilant Radiopharma is a leader in the radiopharmaceutical industry by focusing on developing, manufacturing, commercializing, and distributing high-quality and sustainable diagnostic and therapeutic agents, for the sole purpose of Improving Lives Through Nuclear Medicine™.  We offer customized solutions that combine the clinical expertise of a global manufacturer with the reach of a leading pharmacy network of 46 pharmacies in the United States to support our customers today, while advancing the practice of nuclear medicine, for tomorrow.

Lantheus is the leading radiopharmaceutical-focused company, delivering life-changing science to enable clinicians to Find, Fight and Follow disease to deliver better patient outcomes. Headquartered in Massachusetts with offices in New Jersey, Canada and Sweden, Lantheus has been providing radiopharmaceutical solutions for more than 65 years. For more information, visit www.lantheus.com. 

Lumonus is a specialized Radiation Oncology software company with extensive expertise in global radiation oncology operations, technology, and transformation. 
Lumonus has developed an innovative software platform designed to support care teams in the delivery of high-quality and efficient cancer care by leveraging user-centric workflows, cloud-native architecture, process automation and Artificial Intelligence (AI).

At Merck, our goal is to translate breakthrough science into innovative oncology medicines.  As part of our focus on cancer, Merck is committed to clinical research with one of the largest development programs in the industry. 

Mevion Medical Systems

MIM Software, a GE HealthCare Company, provides indispensable software that standardizes clinical workflows in Radiation Oncology and helps manage and fully leverage the increasing volume and variety of medical imaging required for improved treatment planning. MIM Assistant® provides automation of both routine and complex processes to increase clinical efficiency.

Novartis Pharmaceuticals Corporation  is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach nearly 300 million people worldwide

OPS provides industry-leading operational support to radiation oncology practices nationwide.

Our team uses decades of strategic, regulatory, accounting/finance, and business management expertise to fill any administrative gaps.  OPS is a reliable, guiding partner that is dedicated to the operational freedom of physicians.  An OPS partnership gives you more time to focus on what matters – your patients.
Revenue Cycle, Practice Management, Payor negotiations, Credentialing

PeerSource Oncology specializes in the placement of top locum Radiation Oncology professionals nationwide. As a boutique staffing firm with over 25 years of experience, we provide fully vetted, licensed professionals who are ready for assignments in all 50 states.

PreludeDx:  DCISionRT is intended for women with DCIS considering BCS. The test reports a patient’s 10-year risk of recurrence and predicts RT benefit.

Radformation's suite of solutions leverages intelligent automation and AI to bring efficiency and accuracy to the treatment planning process. From contouring to billing and everything in between, Radformation’s software increases quality, safety, and productivity in over 2,000 radiation oncology clinics worldwide.

 Radiation Business Solutions empowers oncologists and hospitals to elevate their oncology programs, delivering impactful solutions that enhance patient care and drive program success.

RCCS (Revenue Cycle Coding Strategies) is the premier provider of healthcare business solutions. We offer revenue cycle management, coding strategies, strategic consulting, documentation and compliance reviews, custom services, and educational resources across most specialties. Healthcare business solutions. It's in our DNA.

Our sister company, RC Billing, is the largest privately held oncology billing company in the US and the provider of choice for over 350 of the nation’s top medical, radiation, and surgical oncology practices. With over 20 years of experience in both the business and clinical side of oncology practices, RC Billing understands the pressures that today’s oncology providers face.

RSA is the largest independent service provider for Radiation Therapy in the US. With over 75 Field Service Engineers in 40 states, RSA specializes in the expert repair of all Varian, Elekta and Siemens linear accelerators, while also representing the largest parts inventory outside of the OEM. RSA also repairs ultrasound probes and transducers, and provides software solutions for oncology information and treatment systems.

Sensus Healthcare, Inc. is a medical device company specializing in highly effective, non-invasive, minimally invasive, and cost-effective treatments for both oncological and non-oncological conditions.

Sensus offers its proprietary low-energy photon radiotherapy known as superficial radiation therapy (SRT), which is the culmination of more than a decade of research and development, to treat non-melanoma skin cancers and keloids with its SRT-100™, SRT-100+™ and SRT-100 Vision™ systems. With its portfolio of innovative medical device products, Sensus provides revolutionary treatment options to enhance the quality of life of patients around the world.

      

Servier is a global leader in oncology, governed by a non-profit foundation. Servier approaches innovation with a long-term vision, free of influence from fiduciary responsibilities.

Servier takes a One Innovation Engine approach to R&D and is actively seeking alliances, partnerships and acquisitions at various stages of the portfolio.

Renowned for trusted QA hardware and software solutions, Standard Imaging has been a leader in radiation oncology for more than 30 years. Our reliable solutions ensure patient safety, simplify workflows, and enable clinics around the world to provide exceptional cancer care with precision.

Sumitomo Pharma America and Pfizer Oncology are working together to redefine care for millions of patients living with cancer, and aspire to provide medicines that can improve lives and change treatment paradigms. By combining Sumitomo Pharma America’s commitment to purpose-driven science with Pfizer’s deep heritage and leadership in oncology, we are uniquely positioned to provide innovative treatments that fulfill significant unmet needs and make a meaningful difference in people’s lives.

Xstrahl is a medical technology company that designs radiation delivery devices to support clinical teams and cancer researchers. For more than 25 years, Xstrahl has been shaping the development of superficial and orthovoltage radiation therapy and advancing preclinical radiation research. Xstrahl systems are in operation at more than 700 treatment and research facilities worldwide.

Seal Program Sponsor:

C-RAD develops patient-centric and user-friendly Surface Guided Radiation Therapy (SGRT) systems and Workflow Automation solutions for effective radiotherapy treatments and better clinical outcomes. Headquartered in Sweden, C-RAD has supplied hospitals all over the world with more than 1,500 SGRT systems.